OPTOMED.HEOPTOMED.HEHEL
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank50
3Y CAGR+80.4%
5Y CAGR-24.9%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+80.4%/yr
vs -75.0%/yr prior
5Y CAGR
-24.9%/yr
Recent acceleration
Acceleration
+155.4pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20253.43%
202424.27%
2023102.97%
20220.58%
202135.56%
202014.40%
2019-54.01%
2018149.02%
2017-3.56%
20160.00%